Halozyme Therapeutics
HALO
#2173
Rank
โ‚น620.58 B
Marketcap
โ‚น5,039
Share price
1.35%
Change (1 day)
68.99%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): โ‚น142.84

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น150.62. In 2022 the company made an earnings per share (EPS) of โ‚น128.11 a decrease over its 2021 EPS that were of โ‚น246.70.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น142.8411.5%
2022โ‚น128.11-48.07%
2021โ‚น246.70196.88%
2020โ‚น83.10-292%
2019-โ‚น43.28-9.09%
2018-โ‚น47.61-237.5%
2017โ‚น34.62-149.38%
2016-โ‚น70.11211.54%
2015-โ‚น22.51-52.73%
2014-โ‚น47.61-24.66%
2013-โ‚น63.1948.98%
2012-โ‚น42.41145%
2011-โ‚น17.31-64.29%
2010-โ‚น48.47-17.65%
2009-โ‚น58.869.68%
2008-โ‚น53.6793.75%
2007-โ‚น27.7033.33%
2006-โ‚น20.77-4%
2005-โ‚น21.64-3.85%
2004-โ‚น22.51-13.33%
2003-โ‚น25.9783.59%
2002-โ‚น14.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น16.45-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น469.96 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น443.19 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น161.00 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น275.29 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1,219 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA